Edoardo Cignoli : Lilly Psoriasis Treatment Meets Objectives

Eli Lilly said its psoriasis treatment ixekizumab showed positive results in phase 3 studies, preparing the way for its submission to regulatory authorities.



via WSJ.com: US Business http://ift.tt/1BFCBXx